HTLV-I positive progressive spastic paraparesis (TSP) associated with a lymphoid disorder in three Chilean patients.
We describe the clinical and laboratory features in three Caucasian Chilean patients with tropical spastic paraparesis (TSP) associated with/or preceded by a lymphoproliferative disorder involving cutaneous lesions and localised lymphadenopathy. The neurological symptoms and signs were characteristic of TSP and CSF examination revealed the presence of oligoclonal bands. All three patients had a moderate leucocytosis (10-14 x 10(9)/l) with eosinophilia and a minority (2-4%) of circulating atypical polylobed or ATLL-like lymphocytes. Lymph node histology showed a diffuse pattern of infiltration (1 case) and marked expansion of the paracortical zone with convoluted lymphocytes and immunoblasts (2 cases). Skin biopsy demonstrated a dermal lymphoid infiltration with epidermotropism. Antibodies to HTLV-I were detected in the serum and CSF in the three patients and Southern blot analysis of peripheral blood mononuclear cells showed a monoclonal integration of HTLV-I proviral DNA in one case whereas in the two others the pattern was indicative of low level polyclonal integration. All three patients were treated with prednisolone and one with PUVA with transient partial response on the skin and neurological manifestations. Two patients died months to 5 years from presentation and the other is alive 12 years from diagnosis with active neurological and skin disease. The simultaneous occurrence of HTLV-I associated TSP with smouldering ATLL and a cutaneous ATLL or pre-leukaemic form is discussed.
Cartier
L
L
Department of Neurology, Faculty of Medicine, University of Chile, Santiago.
Castillo
J L
JL
Cabrera
M E
ME
Araya
F
F
Matutes
E
E
Ford
A M
AM
Greaves
M F
MF
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology; D015139:Blotting, Southern; D003873:Dermatitis, Exfoliative / Q000150:complications; D005260:Female; D006801:Humans; D015458:Leukemia, T-Cell / Q000150:complications* / Q000473:pathology / Q000821:virology; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D015493:Paraparesis, Tropical Spastic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D011239:Prednisolone / Q000627:therapeutic use; D011533:Proviruses / Q000302:isolation & purification; D012867:Skin / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000914:Antibodies, Viral; D015703:Antigens, CD; D011239:Prednisolone